[{"address1": "1489 W. Warm Springs Road", "address2": "Suite 110", "city": "Henderson", "state": "NV", "zip": "89014", "country": "United States", "phone": "702 825 9872", "website": "https://zurabio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Zura Bio Limited, a clinical-stage biotechnology company, develops medicines for immune and inflammatory disorders in the United States. The company develops Tibulizumab, an immunoglobulin G-single-chain variable fragment bispecific dual-antagonist antibody engineered by the fusion of ixekizumab and tabalumab that neutralizes interleukin (IL)-17A and B-cell activating factor, which is in Phase 2 clinical trial development. It is also developing Torudokimab (ZB-880), a monoclonal antibody that neutralizes IL-33 to prevent ST2-dependent and ST2-independent inflammation, which has completed Phase 1/2 clinical studies; and Crebankitug (ZB-168), a monoclonal antibody that binds and neutralizes the IL-7 receptor alpha chain that impact on diseases driven by IL-7 and thymic stromal lymphopoietin immune pathways, which has completed Phase 1/1b clinical studies. Zura Bio Limited was founded in 2022 and is headquartered in Henderson, Nevada.", "fullTimeEmployees": 30, "companyOfficers": [{"maxAge": 1, "name": "Ms. Kimberly Ann Davis J.D.", "age": 56, "title": "COO, Chief Legal Officer, Interim CEO & Corporate Secretary", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 653839, "exercisedValue": 0, "unexercisedValue": 123066}, {"maxAge": 1, "name": "Dr. Someit  Sidhu M.D.", "age": 34, "title": "Founder & Director", "yearBorn": 1990, "fiscalYear": 2024, "totalPay": 1011553, "exercisedValue": 0, "unexercisedValue": 4233000}, {"maxAge": 1, "name": "Dr. Kiran  Nistala MBBS, Ph.D.", "age": 51, "title": "Chief Medical Officer & Head of Development", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 597411, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Eric  Hyllengren", "age": 49, "title": "Chief Financial Officer", "yearBorn": 1975, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Gary  Whale Ph.D.", "age": 50, "title": "Chief Technology Officer", "yearBorn": 1974, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Theresa  Lowry", "age": 50, "title": "Chief Human Resources Officer", "yearBorn": 1974, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 4.18, "open": 4.11, "dayLow": 3.9373, "dayHigh": 4.2395, "regularMarketPreviousClose": 4.18, "regularMarketOpen": 4.11, "regularMarketDayLow": 3.9373, "regularMarketDayHigh": 4.2395, "payoutRatio": 0.0, "forwardPE": -5.5135136, "volume": 396397, "regularMarketVolume": 396397, "averageVolume": 1641406, "averageVolume10days": 538530, "averageDailyVolume10Day": 538530, "bid": 3.03, "ask": 5.06, "bidSize": 2, "askSize": 2, "marketCap": 271775488, "fiftyTwoWeekLow": 0.97, "fiftyTwoWeekHigh": 4.68, "allTimeHigh": 37.55, "allTimeLow": 0.97, "fiftyDayAverage": 3.2994, "twoHundredDayAverage": 1.86386, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 136479104, "profitMargins": 0.0, "floatShares": 37884530, "sharesOutstanding": 65018058, "sharesShort": 2718321, "sharesShortPriorMonth": 2050530, "sharesShortPreviousMonthDate": 1759190400, "dateShortInterest": 1761868800, "sharesPercentSharesOut": 0.0418, "heldPercentInsiders": 0.27747, "heldPercentInstitutions": 0.60632, "shortRatio": 1.03, "shortPercentOfFloat": 0.0461, "impliedSharesOutstanding": 66611638, "bookValue": 1.665, "priceToBook": 2.4504504, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -53646000, "trailingEps": -0.74, "forwardEps": -0.74, "enterpriseToEbitda": -1.882, "52WeekChange": 0.27102804, "SandP52WeekChange": 0.14261019, "quoteType": "EQUITY", "currentPrice": 4.08, "targetHighPrice": 26.0, "targetLowPrice": 2.0, "targetMeanPrice": 13.33333, "targetMedianPrice": 13.0, "recommendationMean": 1.42857, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 6, "totalCash": 139016992, "totalCashPerShare": 2.138, "ebitda": -72528000, "totalDebt": 0, "quickRatio": 5.454, "currentRatio": 5.582, "returnOnAssets": -0.27239, "returnOnEquity": -0.45009997, "freeCashflow": -23932376, "operatingCashflow": -53361000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "ZURA", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Zura Bio Limited", "longName": "Zura Bio Limited", "regularMarketChangePercent": -2.39234, "regularMarketPrice": 4.08, "postMarketTime": 1763161951, "regularMarketTime": 1763154001, "exchange": "NCM", "messageBoardId": "finmb_1783060399", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketDayRange": "3.9373 - 4.2395", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1641406, "fiftyTwoWeekLowChange": 3.11, "fiftyTwoWeekLowChangePercent": 3.2061853, "fiftyTwoWeekRange": "0.97 - 4.68", "fiftyTwoWeekHighChange": -0.5999999, "fiftyTwoWeekHighChangePercent": -0.1282051, "fiftyTwoWeekChangePercent": 27.102804, "earningsTimestamp": 1763040600, "earningsTimestampStart": 1763040600, "earningsTimestampEnd": 1763040600, "isEarningsDateEstimate": false, "corporateActions": [], "marketState": "CLOSED", "epsTrailingTwelveMonths": -0.74, "epsForward": -0.74, "fiftyDayAverageChange": 0.78059983, "fiftyDayAverageChangePercent": 0.23658842, "twoHundredDayAverageChange": 2.2161398, "twoHundredDayAverageChangePercent": 1.1890055, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2023-03-21", "averageAnalystRating": "1.4 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1679405400000, "postMarketChangePercent": 0.49019563, "postMarketPrice": 4.1, "postMarketChange": 0.01999998, "regularMarketChange": -0.0999999, "displayName": "Zura Bio", "trailingPegRatio": null, "__fetch_time": "2025-11-15"}]